Monday, May 12, 2025
spot_img

Disclosure of transactions in on shares from May 05th to May 09th, 2025

Nanterre, May 12th, 2025   

                  

Disclosure of transactions in on shares

from May 05th to May 09th, 2025

Within the framework of the authorization granted by the General Meeting of VINCI SA of April 17th 2025, to trade in its shares and in accordance with the regulations relating to share buybacks, VINCI SA (LEI:213800WFQ334R8UXUG83) declares the purchases of treasury shares below (FR0000125486), carried out from May 05th to May 09th, 2025:

I – Aggregate presentation by day and by market

Issuer’s name Date of transaction Identifying code of financial instrument Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares in Euro Market (MIC code)
VINCI 06/05/2025 FR0000125486 50 000 125,4087 XPAR
VINCI 06/05/2025 FR0000125486 20 000 125,4501 CEUX
VINCI 07/05/2025 FR0000125486 72 041 125,3982 XPAR
VINCI 07/05/2025 FR0000125486 25 061 125,3867 CEUX
VINCI 07/05/2025 FR0000125486 1 457 125,3394 TQEX
VINCI 07/05/2025 FR0000125486 1 441 125,3545 AQEU
VINCI 08/05/2025 FR0000125486 52 865 125,6589 XPAR
VINCI 08/05/2025 FR0000125486 28 000 125,6910 CEUX
VINCI 08/05/2025 FR0000125486 4 548 125,6905 TQEX
VINCI 08/05/2025 FR0000125486 4 587 125,7002 AQEU
VINCI 09/05/2025 FR0000125486 50 000 126,0666 XPAR
VINCI 09/05/2025 FR0000125486 30 000 126,1548 CEUX
VINCI 09/05/2025 FR0000125486 4 666 126,2085 TQEX
VINCI 09/05/2025 FR0000125486 4 551 126,1720 AQEU
    TOTAL 349 217 125,6537  

II – Details of transactions

In accordance with Article 5 (1) (b) of Regulation (EU) No 596/2014 (Regulation on market abuse), detailed information is available on the VINCI website :

https://www.vinci.com/vinci.nsf/fr/finances-bourse-actionnariat-transactions/pages/index.htm

                                                                 ______________________

Attachment

  • Communique VINCI – declaration hebdo- rachat d’actions from 05-05-25 to 09-05-25 vGB

Powered by SlickText.com

Hot this week

Team, Inc. Reports First Quarter 2025 Results

SUGAR LAND, Texas, May 12, 2025 (GLOBE...

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) --...

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results

First of several clinical updates through mid-2026 accepted for...

ZyVersa Therapeutics Reports First Quarter 2025 Financial Results and Highlights Pipeline Progress

KEY HIGHLIGHTS First patient expected to start therapy...

Topics

spot_img

Related Articles

Popular Categories

spot_img